FDA Home Page | Search
FDA Site | FDA A-Z Index | Contact
FDA | FDA Centennial
MOU number: 225-98-8000
I. PURPOSE
The Food and Drug Administration (FDA) and the Indian Health Service (IHS), U.S. Department of Health and Human Services (DHHS), have mutual interests in fostering improved health care and access to policy and education programs.
FDA and IHS intend to work to develop a more cohesive relationship to mutually address American Indian and Alaska Native issues within the context of each organization's jurisdiction. FDA and IHS agree to work together to promote and support appropriate ongoing DHHS and organizationally specific initiatives, such as:
This MOU establishes policies and principles by which the parties may be guided when executing specific interagency agreements for the exchange of funds, services, or personnel.
II.
AUTHORITY
Food and Drug Administration: Section 903 of the FFDCA (21 U.S.C. 393), Section 301 of the PHSA, (42 U.S.C. 241), Sections 1701 et seq. of the PHSA (42 U.S.C. 300u et seq.)
Indian Health Service: Transfer Act (42 U.S.C. 2001) of 1954.
III. BACKGROUND
The FDA and the IHS have been independently conducting activities, in the context of their jurisdictions, to improve the knowledge base of American Indian and Alaska Native populations and to involve these individuals in their respective processes. The FDA and the IHS recognized that the success of those efforts can be enhanced by greater collaboration.
The IHS has focused its outreach activities primarily on the needs of American Indian and Alaska Native populations. Similarly, the FDA has focused its efforts primarily upon the needs of the general population with intermittent emphasis upon American Indian and Alaska Native populations.
The goal of the FDA and the IHS collaborations will be to accomplish the following:
(1) More effectively interface with the IHS, the National Indian Health Board, the National Congress of American Indians, Regional Health Boards, and other DHHS components by:
--soliciting tribal advice and recommendations on approaches to achieve appropriate levels of effective and efficient involvement of American Indians and Alaska Natives in the FDA's regulatory and outreach processes;
--Enhancing local consultations and collaborations with tribal governments, when appropriate;
--receiving assistance in improving involvement of American Indians and Alaska Natives in Agency policy initiatives;
--discussing collaborative approaches to promote the safe and practical use of FDA-regulated products among American Indian and Alaska Native populations;
--discussing approaches and establishing distribution systems for materials through IHS Tribal and Urban Indian Health Programs, Indian schools, community colleges and universities, IHS Medical Centers and the Department of Veterans Affairs' regional medical centers;
(2) Improve access of American Indians and Alaska Natives to FDA generated information on health risks and policy issues;
(3) provide community based organizations and concerned individuals with the opportunities to have appropriate input into regulatory processes such as;
--encourage participation of American Indians and Alaska Natives in Agency-sponsored conferences, meetings, focus groups, and consumer studies;
--promote opportunities to serve on the FDA's advisory committees and panels, science boards, and in research;
(4) provide FDA and IHS officials and managers with the perspectives on America Indian and Alaska Native health care and education needs and policy issues;
(5) promote diversity in the planning and application of existing educational programs and services that encourage youth to pursue careers in the sciences, math, and other disciplines that may lead to careers in the advanced sciences, engineering and the health professions; and
(6) continue recruitment efforts to American Indian and Alaska Native populations through programs such as the Cooperative Education Programs (CO-OP), Commissioned Officer Student Training and Extern Program (COSTEP), fellowships, personnel exchanges, and summer employment programs through Tribal Colleges and Universities and professional associations.
IV. SCOPE OF WORK
The FDA and the IHS hereby express their firm intentions to jointly address American Indian and Alaska Native issues within the context of regulatory processes and programs conducted by the FDA primarily for the general U.S. population, as resources permit. Given the diversity of education, knowledge, understanding and cultures within the American Indian and Alaska Native populations, the IHS will work with FDA to enhance its activities with American Indian and Alaska Native populations.
FDA and IHS have established formal liaisons for both Agencies that will foster an information exchange on all aspects of the MOU. Other functions of the Agency liaisons may include the following:
V. DURATION OF AGREEMENT
This MOU will become effective upon acceptance by both parties and will continue in effect indefinitely. This MOU may be modified by mutual written consent or terminated by either party upon 60 day advance notice to the other party.
VI. LIAISONS/PROJECT OFFICERS
Mary C. Wallace
Director of Consumer Programs
and FDA Minority Health Liaison
Food and Drug Administration
Office of External Affairs
Office of Consumer Affairs
5600 Fishers Lane, Room 16-85, HFE-3
Rockville, MD 20857
(301) 827-4406
Fax (301) 443-9767
Phyllis Eddy
Special Assistant to the Director
of Health Operations
Indian Health Service
Office of the Director
5600 Fishers Lane, Room 6-22
Rockville, MD 20857
(301) 443-7261
Fax (301) 481-3192
INDIAN HEALTH SERVICE
AREA DIRECTORS
Donald B. Bad Mocassin
Aberdeen Area Federal Building 115 Fourth Avenue, SE Aberdeen, SD 57401 PHONE: (605) 226-7581 Fax: (605) 226-7541 |
Richard Ramirez OHPRD (Acting) 7900 South "J" Stock Road Tucsan, AZ 85746-9352 PHONE: (520)295-2406 Fax: (520) 295-2602 |
Randy Grinnell Oklahoma City Area (Acting) 3625 NW 56th Street Five Corporate Plaza Oklahoma City, OK 73112 PHONE: (405) 945-3768 Fax: (405) 951-3780 |
Richie K. Grinnell Albuquerque Area (Acting) 5338 Montgomery Blvd. N.E. Room 123 Albuquerque, NM 87109-1311 PHONE: (505) 248-4500 Fax: (505) 248-4624 |
Kathleen Annette, M.D. Bemidji Area 219 Federal Building Bemidji, MN 56601 PHONE: (218) 759-3412 Fax: (218) 759-3510 |
Joyce M. Reyes Portland Area (Acting) 1220 SW Third Avenue Room 476 Portland, OR 97204-2892 PHONE: (503) 326-2020 Fax: (503) 326-7280 |
Duane L. Jeanotte Billings Area P.O. Box 2143 Billings, MT 59103 FED. EX. ADDRESS: 2900 4th Avenue North Billings, MT 59103 PHONE: (406) 247-7107 Fax: (406) 247-7230 |
Don J. Davis Phoenix Area Two Renaissance Square Suite 600 40 N. Central Avenue Phoenix, AZ 85004 PHONE: (602) 364-5039 FAX: (602) 364-5042 |
John Hubbard, Jr. Navajo Area P.O. Box 9020 Window Rock, AZ 86515-9020 FED EX ADDRESS: Highway 264 St. Michaels, AZ 86511 PHONE: (520) 871-5811 Fax: (520) 871-5872 |
Michael D. Tiger Nashville Area 711 Stewarts Ferry Pike Nashville, TN 37214-2634 PHONE: (615) 736-2400 Fax: (615) 736-2406 |
Margo D. Kerrigan California Area 1825 Bell Street Suite 200 Sacramento, CA 95825-1097 PHONE: (916) 566-7001 Fax: (916) 566-7053 |
Eleanore Robertson Deputy Director of HQ Operations/HQW 5300 Homestead Road, NE Albuquerque, NM 87110 PHONE: (505) 248-4101 Fax: (505) 248-4115 |
David A. Schraer, M.D. Alaska Area (Acting) 4141 Ambassador Drive Anchorage, AK 99508 Phone: (907) 729-3687 Fax: (907) 729-3689 |
Approved and Accepted Signed by: Director, Indian Health Service Date: July 9, 1997 |
Approved and Accepted Signed by: Lead Deputy Commissioner Date: July 9, 1997 |